Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -2.0% | +3.5% | 2 / 3 | -4.3% | -0.89 pp | +2.28 pp | +46.0% | 0.10 | 5.07 | 279 | −4,3% | 187 | −0,9% | 5.07 | 7.99 | −36,6% |
| Pts | 0 | 0 | 8 | 0 | 4 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 40.100 (close price on 2026-10-19)EPS (TTM): 7.912
Financial charts
1.Revenue & growth
VND bn279Q2/26
1.Revenue & growth
VND bn279Q2/26
2.Profit & growth
VND bn188Q2/26
3.Profit mix (Penman)
VND bn943Q2/26
4.Margins & cost structure
%77.6%Q2/26
5.Returns & cash cycle
% · days414%Q2/26
6.Earnings quality & cash
VND bn672Q2/26
7.Asset structure
VND bn2.311Q2/26
8.Funding & debt health
VND bn · times2.311Q2/26
9.Revenue backlog
VND bn6,45Q2/26
10.Valuation
times · %5,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.828Q2/26
Adjusted EPS growth, latest quarter
-1.3%
Average adjusted EPS growth, 3 quarters
3.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
1.0%
Source: vnstockData through Q2/26